While the labour market may be tight for the pharmaceutical industry, organisations can get ahead of growing pains by prioritising their people. Growing a strong and stable staff is possible ...
Co. withdrew the painkiller Vioxx from the market last September after the drug was linked to increased risks of heart attack and stroke, more than one metabolomics researcher shook their heads and ...
The Independent on MSN6mon
Former Growing Pains star sparks backlash with rant about ‘Marxist’ schools, atheists and drag queensFormer Growing Pains star Kirk Cameron has sparked a social ... drag queens, strippers, drug dealers, and you name it,” he ...
About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...
In December 2017, the US Food & Drug Administration (FDA) approved Luxturna from Spark Therapeutics — the first gene therapy to win market approval in the US. Several other gene therapy programs ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback